1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. North America Diabetic Foot Ulcer Treatment Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. North America Diabetic Foot Ulcer Treatment Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. North America Diabetic Foot Ulcer Treatment Market Regional Analysis
6.2 North America Diabetic Foot Ulcer Treatment Market Revenue 2019-2028 (US$ Million)
6.3 North America Diabetic Foot Ulcer Treatment Market Forecast Analysis
7. North America Diabetic Foot Ulcer Treatment Market Analysis – by Type
7.1 Advanced Wound Care Dressings
- 7.1.1 Overview
- 7.1.2 Advanced Wound Care Dressings: North America Diabetic Foot Ulcer Treatment Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.2 Biologics
- 7.2.1 Overview
- 7.2.2 Biologics: North America Diabetic Foot Ulcer Treatment Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.3 Therapy Device
- 7.3.1 Overview
- 7.3.2 Therapy Device: North America Diabetic Foot Ulcer Treatment Market – Revenue and Forecast, 2019-2028 (US$ Million)
8. North America Diabetic Foot Ulcer Treatment Market Analysis – by Ulcer Type
8.1 Neuropathic Ulcers
- 8.1.1 Overview
- 8.1.2 Neuropathic Ulcers: North America Diabetic Foot Ulcer Treatment Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.2 Ischemic Ulcers
- 8.2.1 Overview
- 8.2.2 Ischemic Ulcers: North America Diabetic Foot Ulcer Treatment Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.3 Neuro-ischemic Ulcers
- 8.3.1 Overview
- 8.3.2 Neuro-ischemic Ulcers: North America Diabetic Foot Ulcer Treatment Market – Revenue and Forecast, 2019-2028 (US$ Million)
9. North America Diabetic Foot Ulcer Treatment Market Analysis – by End User
9.1 Hospitals
- 9.1.1 Overview
- 9.1.2 Hospitals: North America Diabetic Foot Ulcer Treatment Market – Revenue and Forecast, 2019-2028 (US$ Million)
9.2 Ambulatory Surgery Centers
- 9.2.1 Overview
- 9.2.2 Ambulatory Surgery Centers: North America Diabetic Foot Ulcer Treatment Market – Revenue and Forecast, 2019-2028 (US$ Million)
9.3 Home Care
- 9.3.1 Overview
- 9.3.2 Home Care : North America Diabetic Foot Ulcer Treatment Market – Revenue and Forecast, 2019-2028 (US$ Million)
10. North America Diabetic Foot Ulcer Treatment Market – North America Analysis
10.1 Overview
10.2 North America
- 10.2.1 North America Diabetic Foot Ulcer Treatment Market Breakdown, by Key
Country, 2022 and 2028 (%)
- 10.2.1.1 North America Diabetic Foot Ulcer Treatment Market – Revenue and
Forecast Analysis – by Country
- 10.2.1.1 US:
North America Diabetic Foot Ulcer Treatment Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.1.1 US: North America Diabetic Foot Ulcer Treatment Market Breakdown, by Type
- 10.2.1.1.2 US: North America Diabetic Foot Ulcer Treatment Market Breakdown, by Ulcer Type
- 10.2.1.1.3 US: North America Diabetic Foot Ulcer Treatment Market Breakdown, by End User
- 10.2.1.2 Canada:
North America Diabetic Foot Ulcer Treatment Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.2.1 Canada: North America Diabetic Foot Ulcer Treatment Market Breakdown, by Type
- 10.2.1.2.2 Canada: North America Diabetic Foot Ulcer Treatment Market Breakdown, by Ulcer Type
- 10.2.1.2.3 Canada: North America Diabetic Foot Ulcer Treatment Market Breakdown, by End User
- 10.2.1.3 Mexico :
North America Diabetic Foot Ulcer Treatment Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.3.1 Mexico : North America Diabetic Foot Ulcer Treatment Market Breakdown, by Type
- 10.2.1.3.2 Mexico : North America Diabetic Foot Ulcer Treatment Market Breakdown, by Ulcer Type
- 10.2.1.3.3 Mexico : North America Diabetic Foot Ulcer Treatment Market Breakdown, by End User
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Industry Landscape
12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments
13. Company Profiles
13.1 3M
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 B. Braun Melsungen AG
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Cardinal Health Inc
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Coloplast Group
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 ConvaTec Group Plc
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Kerecis
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Medline Industries, Inc.
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 MiMedx
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Mölnlycke Health Care AB.
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 Organogenesis Inc.
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
13.11 Smith & Nephew
- 13.11.1 Key Facts
- 13.11.2 Business Description
- 13.11.3 Products and Services
- 13.11.4 Financial Overview
- 13.11.5 SWOT Analysis
- 13.11.6 Key Developments
13.12 URGO
- 13.12.1 Key Facts
- 13.12.2 Business Description
- 13.12.3 Products and Services
- 13.12.4 Financial Overview
- 13.12.5 SWOT Analysis
- 13.12.6 Key Developments
14. Appendix
14.1 About Business Market Insights
14.2 List of Abbreviations